Riskpilot← Back to searchSign inGet full accessVoronkova Clinic AB
ABActiveOrg 5592659923Riddargatan 3 BBeauty care and other beauty treatment activities · NACE 9622Est. 20200 employees
Revenue 2024
SEK 312K
+3% vs 2023
EBITDA margin
7.7%
+14% vs 2023
Equity ratio
92.1%
Financial strength
Net profit 2024
SEK 15K
-6% vs 2023
| Revenue | SEK 312K | +3% |
| EBITDA | SEK 24K | +14% |
| Net profit | SEK 15K | -6% |
| Total assets | SEK 76K | -11% |
| Equity | SEK 70K | +25% |
| Employees | 0 | — |
Legal name
Voronkova Clinic AB
Org number
5592659923
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
5 augusti 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Då minst halva antalet styrelsesuppleanter ska vara bosatta inom EES uppfyller företaget inte kravet på bosättning.
Company purpose
Handel med varor och tjänster inom företrädesvis estetiska behandlingar, hudvård, medicinsk konsultation, vård och omsorg samt event inom mode, skönhet och hälsa.
Address
Riddargatan 3 B
Email
valentina_vallgren@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 32 | 422 | — | 303 | 312 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −12 | 21 | 0 | 21 | 24 |
| Depreciation & amort. | −0 | −0 | — | −0 | −0 |
| EBIT | −12 | 21 | 0 | 21 | 24 |
| Net financials | — | −1 | — | — | −6 |
| Profit before tax | −12 | 20 | 0 | 21 | 19 |
| Tax | −0 | −2 | — | −5 | −4 |
| Net profit | −12 | 18 | — | 16 | 15 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 48 | 145 | — | 85 | 76 |
| Equity | 13 | 31 | — | 56 | 70 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 35 | 114 | — | 29 | 6 |
| Total debt | 35 | 114 | — | 29 | 6 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20202024
Equity ratio
92.1%
This company
38.2%
Market median
+141% vs market
20202024
Return on equity
21.4%
This company
18.4%
Market median
+16% vs market
20202024
Net profit margin
4.8%
This company
8.1%
Market median
-41% vs market
20202024
Asset turnover
4.11×
This company
1.12×
Market median
+267% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-08-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
VV Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Voronkova Clinic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Valentina Vallgren Ousova | Chief Executive Officer | 0 companies |
| Erik Andreas Pettersson Brink | Deputy Board Member | 0 companies |
| Oleksandr Usov | Deputy Board Member | 0 companies |